BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21167755)

  • 1. The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.
    Yu Y; Hayward GS
    Immunity; 2010 Dec; 33(6):863-77. PubMed ID: 21167755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
    Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
    J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E3 ubiquitin ligase NEURL3 promotes innate antiviral response through catalyzing K63-linked ubiquitination of IRF7.
    Qi F; Zhang X; Wang L; Ren C; Zhao X; Luo J; Lu D
    FASEB J; 2022 Aug; 36(8):e22409. PubMed ID: 35792897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxO1 negatively regulates cellular antiviral response by promoting degradation of IRF3.
    Lei CQ; Zhang Y; Xia T; Jiang LQ; Zhong B; Shu HB
    J Biol Chem; 2013 May; 288(18):12596-604. PubMed ID: 23532851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Cbl-mediated ubiquitination of IRF3 negatively regulates IFN-β production and cellular antiviral response.
    Zhao X; Zhu H; Yu J; Li H; Ge J; Chen W
    Cell Signal; 2016 Nov; 28(11):1683-93. PubMed ID: 27503123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms.
    Qin Y; Zhou MT; Hu MM; Hu YH; Zhang J; Guo L; Zhong B; Shu HB
    PLoS Pathog; 2014 Sep; 10(9):e1004358. PubMed ID: 25254379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation.
    Yu Y; Wang SE; Hayward GS
    Immunity; 2005 Jan; 22(1):59-70. PubMed ID: 15664159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin E3 ligase MID1 inhibits the innate immune response by ubiquitinating IRF3.
    Chen X; Xu Y; Tu W; Huang F; Zuo Y; Zhang HG; Jin L; Feng Q; Ren T; He J; Miao Y; Yuan Y; Zhao Q; Liu J; Zhang R; Zhu L; Qian F; Zhu C; Zheng H; Wang J
    Immunology; 2021 Jul; 163(3):278-292. PubMed ID: 33513265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3.
    Li R; Pan Y; Shi DD; Zhang Y; Zhang J
    Antiviral Res; 2013 Nov; 100(2):546-54. PubMed ID: 24036127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
    Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
    Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.
    Lutz LM; Pace CR; Arnold MM
    J Virol; 2016 Jul; 90(13):6036-48. PubMed ID: 27099313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 ubiquitin ligase ASB8 negatively regulates interferon via regulating TBK1/IKKi homeostasis.
    Guo Y; Li R; Tan Z; Shi J; Fu Y; Song Y; Zhu M; Zhang L; Huang J
    Mol Immunol; 2020 May; 121():195-203. PubMed ID: 32298923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
    Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3.
    Higgs R; Ní Gabhann J; Ben Larbi N; Breen EP; Fitzgerald KA; Jefferies CA
    J Immunol; 2008 Aug; 181(3):1780-6. PubMed ID: 18641315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication.
    Chung WC; Lee S; Kim Y; Seo JB; Song MJ
    PLoS Pathog; 2021 Jan; 17(1):e1009261. PubMed ID: 33508027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production.
    Young JA; Sermwittayawong D; Kim HJ; Nandu S; An N; Erdjument-Bromage H; Tempst P; Coscoy L; Winoto A
    J Biol Chem; 2011 Feb; 286(8):6521-31. PubMed ID: 21183682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.
    Kubota T; Matsuoka M; Chang TH; Tailor P; Sasaki T; Tashiro M; Kato A; Ozato K
    J Biol Chem; 2008 Sep; 283(37):25660-25670. PubMed ID: 18635538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity.
    Saira K; Zhou Y; Jones C
    J Virol; 2007 Apr; 81(7):3077-86. PubMed ID: 17215277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.
    Gould F; Harrison SM; Hewitt EW; Whitehouse A
    J Virol; 2009 Jul; 83(13):6727-38. PubMed ID: 19369342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.